Source:Journal of Allergy and Clinical Immunology
Author(s): Adam K.A. Wright, Cathryn Weston, Batika M.J. Rana, Christopher E. Brightling, David J. Cousins
Teaser
Capsule summary: Group 2 innate lymphoid cells (ILC2s) are upstream regulators of IL-5-dependent eosinophil function in asthma. We've shown that ILC2s do not express the IL-5R and thus IL-5R-dependent therapeutic interventions (e.g. Benralizumab) are unlikely to be mediated directly on ILC2s.http://ift.tt/2qW0NaR
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου